GABRG2 rs861020: Understanding This Common Genetic Variant
The rs861020 variant is a common genetic change located within the GABRG2 gene. While rare, specific mutations in this gene are linked to various epilepsy syndromes, research into common variants like rs861020 has generally not shown a strong, direct link to common forms of epilepsy.
What each genotype means
Typical GABRG2 genotype
This genotype represents the most common genetic sequence observed in the general population for this location in the GABRG2 gene. Research indicates that GABRG2 is an established epilepsy gene, but this specific genotype is not associated with the rare, pathogenic mutations linked to epilepsy syndromes. You should discuss any personal or family history of seizures with a healthcare provider, as epilepsy risk is complex and involves many genetic and environmental factors.
This is the most common genotype found across all major global populations.
Heterozygous variant carrier
Carrying one copy of this variant means you have a different genetic sequence than the most common form. While GABRG2 mutations are known to be associated with autosomal dominant epilepsy syndromes, the clinical significance of this specific variant must be interpreted in the context of your personal and family health history. Please consult with a genetic counselor or neurologist to understand if this finding is relevant to your health, as many variants in this gene have incomplete penetrance.
This genotype is observed at varying frequencies depending on ancestry, though it remains less common than the homozygous reference genotype.
Homozygous variant carrier
This genotype indicates that both copies of the gene carry this specific variant. Because GABRG2 is linked to epilepsy syndromes with incomplete penetrance, the presence of this genotype does not guarantee a clinical diagnosis. You should discuss this result with a medical professional who can evaluate it alongside your clinical history and any symptoms, as the impact of such variants can be influenced by your overall genetic background.
This genotype is rare in the general population across most ancestral groups.
What is rs861020 and Where is it Located?
The rs861020 variant is a single nucleotide polymorphism (SNP) found within the GABRG2 gene. This gene is located on chromosome 5 and provides instructions for creating the gamma-2 subunit of the GABA-A receptor. GABA-A receptors are critical components of the human nervous system, acting as the primary inhibitory neurotransmitter receptors in the brain. By allowing chloride ions to flow into neurons, these receptors help dampen electrical activity, effectively acting as a 'brake' for the brain's signaling pathways. Because rs861020 is a common variant, it is found frequently in the general population across various ancestries. Scientists study such variants to determine if they influence how these receptors function or if they contribute to individual differences in neurological health. While the GABRG2 gene itself is well-known for its involvement in rare, inherited epilepsy syndromes, the presence of a common variant like rs861020 does not automatically imply a health condition.
The Role of GABRG2 in Brain Function
The GABRG2 gene is essential for the proper assembly and trafficking of GABA-A receptors. These receptors are pentameric, meaning they are composed of five protein subunits that form a channel. The gamma-2 subunit, encoded by GABRG2, is particularly important because it confers specific properties to the receptor, such as sensitivity to benzodiazepines and the ability to form high-conductance channels. When the GABRG2 gene functions correctly, it ensures that these inhibitory receptors are correctly placed at the synapses between neurons. If the gene is altered by rare, pathogenic mutations, it can lead to a loss or gain of function in these receptors, which may disrupt the balance between excitation and inhibition in the brain. This imbalance is a hallmark of many epilepsy syndromes. However, it is important to distinguish between rare, highly disruptive mutations and common variants like rs861020, which are typically part of the normal spectrum of human genetic diversity.
Research Associations and Evidence Strength
Research into GABRG2 has primarily focused on rare, pathogenic mutations that cause severe, autosomal dominant epilepsy syndromes, such as Genetic Epilepsy with Febrile Seizures Plus (GEFS+). In these rare cases, the evidence linking specific mutations to disease is strong. Conversely, studies investigating common variants within GABRG2, including rs861020, have generally failed to find a significant association with common, complex forms of epilepsy. Large-scale case-control studies have examined whether these common polymorphisms increase the risk of developing epilepsy in the general population, but the results have been largely negative. This suggests that while the GABRG2 gene is a critical 'epilepsy gene' when it carries rare, damaging mutations, common genetic variation in this region does not appear to play a major role in the development of common epilepsy syndromes. The evidence for rs861020 as a standalone risk factor for epilepsy is considered weak or non-existent based on current peer-reviewed literature.
What You Can and Cannot Do With This Information
Understanding your genetic profile can be informative, but it is vital to interpret results like rs861020 within the correct context. Because this is a common variant not strongly linked to disease, it should not be used to predict health outcomes or diagnose medical conditions. Genetic testing results for common variants are not a substitute for professional medical advice. If you have concerns about neurological health, seizures, or family history of epilepsy, you should consult with a neurologist or a genetic counselor. They can provide a clinical evaluation that considers your entire medical history, rather than focusing on a single SNP. Never make changes to medications or health routines based on genetic data without first discussing them with your clinician or pharmacist. Genetic information is a tool for scientific understanding, but clinical decisions must always be guided by a qualified healthcare provider who can interpret findings in the context of your overall health.
How common is this variant?
The rs861020 variant is a common polymorphism, meaning its various genotypes are found at significant frequencies across most global human populations.
Frequently asked questions
Is rs861020 a cause of epilepsy?
No. While rare, specific mutations in the GABRG2 gene are known to cause epilepsy, the common variant rs861020 has not been shown to have a strong association with common forms of epilepsy.
Should I be worried if I have the G allele for rs861020?
No. The rs861020 variant is a common genetic difference found in many healthy individuals. It is not considered a diagnostic marker for any disease.
Does this variant affect how I respond to medication?
There is no established evidence that rs861020 influences medication response. Always consult your pharmacist or doctor before making any changes to your prescribed treatments.
Where can I find more information about GABRG2?
You can search resources like MedlinePlus Genetics or the NCBI Gene database for comprehensive information on the GABRG2 gene and its role in human health.
Sources & further reading
Educational information only, last refreshed 10/17/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs861020?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in GABRG2
This variant in the GABRG2 gene is associated with variations in response to certain anticonvulsant medications and epilepsy susceptibility.
Variant in GABRG2, a gene where mutations can alter GABA-A receptor function and influence seizure thresholds.
Mutations in GABRG2 are linked to a spectrum of epilepsy ranging from simple febrile seizures to severe developmental and epileptic encephalopathies.
This variant is located in the GABRG2 gene, which encodes the gamma-2 subunit of the GABA-A receptor; variants in this gene are associated with a spectrum of epilepsy syndromes.
A common variant in GABRG2, a gene encoding a GABA-A receptor subunit linked to various epilepsy phenotypes including febrile seizures and GEFS+.
Linked to GABA-A receptor subunit dysfunction, a known mechanism for inherited epilepsy syndromes.